- Home
- XERS vs NFJ Comparison
XERS vs NFJ Comparison
Compare XERS & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | NFJ |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | NFJ |
|---|---|---|
| Price | $7.32 | $12.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.43 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 223.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $266,137,000.00 | N/A |
| Revenue This Year | $44.37 | N/A |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | N/A |
| 52 Week Low | $3.14 | $10.45 |
| 52 Week High | $10.08 | $12.86 |
Technical Indicators
Market Signals| Indicator | XERS | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 47.18 |
| Support Level | $6.95 | $12.58 |
| Resistance Level | $7.26 | $13.29 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | 0.10 | -0.04 |
| Stochastic Oscillator | 86.67 | 30.56 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.